Activity of Trovafloxacin Against Micro-Organisms Isolated from Diabetic Patients with Lower Extremity Infections

Weiss, K.; Laverdiére, M.; Restieri, C.; Poirier, L.
December 1999
Drugs;Dec1999 Supplement 2, Vol. 58 Issue 6, p154
Academic Journal
Examines the in vitro activity of quinolones against microorganisms isolated from patients with diabetic foot infections. Methods; Results; Discussion.


Related Articles

  • Bacterial Resistance to Ciprofloxacin in Greece: Results from the National Electronic Surveillance System. Vatopoulos, A.C.; Kalapothaki, V.; Legakis, N.J. // Emerging Infectious Diseases;May/Jun99, Vol. 5 Issue 3, p471 

    Provides information on the 1997 susceptibility data from the National Electronic System for Surveillance of Antimicrobial Resistance which revealed that Greece has high rates of ciprofloxacin resistance. Frequency of ciprofloxacin-resistant isolates for most species; Factors that may...

  • Microbial transformations of antimicrobial quinolones and related drugs. Parshikov, Igor; Sutherland, John // Journal of Industrial Microbiology & Biotechnology;Dec2012, Vol. 39 Issue 12, p1731 

    The quinolones are an important group of synthetic antimicrobial drugs used for treating bacterial diseases of humans and animals. Microorganisms transform antimicrobial quinolones (including fluoroquinolones) and the pharmacologically related naphthyridones, pyranoacridones, and cinnolones to a...

  • Mechanisms of Action and Resistance of Older and Newer Fluoroquinolones. Hooper, David C. // Clinical Infectious Diseases;8/1/2000 Supplement 2, Vol. 31, pS24 

    Explores the mechanisms of older and newer fluoroquinolone action and resistance. Targets of quinolone action and resistance by alterations in targets; Efflux mechanisms of resistance; Selection of resistance mutations by newer fluoroquinolones.

  • Ofloxacin Selects First-Step ParC Mutations in Mycoplasma hominis Whereas Sparfloxacin Selects for First-Step GyrA Mutations. Kenny, G.E.; Young, P.A.; Cartwright, F.D.; Sjostrom, K.E.; Huang, W.M. // Drugs;Dec1999 Supplement 2, Vol. 58 Issue 6, p123 

    Determines the frequency of mutation to quinolone resistance in Mycoplasma hominis. Materials and methods; Results and discussion.

  • TRENDS IN PATTERNS OF RESISTANCE AMONG MICRO ORGANISMS CAUSING NEONATAL SEPSIS IN PESHAWAR. Khan, Qamar Ali; Iqbal, Hamid; Rehman, Habibur // JPMI: Journal of Postgraduate Medical Institute;2012, Vol. 26 Issue 2, p165 

    Objective: To report the spectrum and patterns of resistance among micro organisms causing neonatal sepsis in a tertiary care neonatal setting. Methodology: This descriptive study was conducted in Special Care Baby Unit (SCBU) Department of Child Health and Microbiology Section Department of...

  • Mycobacterium peregrinum : bactericidal activity of antibiotics alone and in combination. Ana Santos; Rosa Cremades; Juan Rodriguez; Eduardo Garcia-Pachon; Montserrat Ruiz; Gloria Royo // Journal of Infection & Chemotherapy (Springer Science & Business;Jun2008, Vol. 14 Issue 3, p262 

    Abstract   Mycobacterium peregrinum is a rapidly growing mycobacterium that is occasionally associated with disease at different locations. At present, little information is available on antibiotic activity against this microorganism. For this reason, we have carried out a study on the in...

  • Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Engberg, Jorgen; Gerner-Smidt, Peter; Aarestrup, Frank M.; Taylor, Diane E.; Nachamkin, Irving; Engberg, J; Aarestrup, F M; Taylor, D E; Gerner-Smidt, P; Nachamkin, I // Emerging Infectious Diseases;Jan/Feb2001, Vol. 7 Issue 1, p24 

    The incidence of human Campylobacter jejuni and C. coli infections has increased markedly in many parts of the world in the last decade as has the number of quinolone-resistant and, to a lesser extent, macrolide-resistant Campylobacter strains causing infections. We review macrolide and...

  • Newer fluoroquinolones preferred antimicrobial prophylaxis. Durrie, Deniel S.; Trattler, William // Ophthalmology Times;11/1/2004, Vol. 29 Issue 21, p21 

    The article focuses on newer fluoroquinolones, a preferred antimicrobial prophylaxis. The fourth-generation fluoroquinolones gatifloxacin 0.3 percent and moxifloxacin 0.5 percent provide safe, potent, and broad-spectrum coverage against bacterial pathogens that are important in post-refractive...

  • Effects of EDP-420 on penicillin-resistant and quinolone- and penicillin-resistant pneumococci in the rabbit meningitis model. Armin Stucki; Peter Gerber; Fernando Acosta; Marianne Cottagnoud; Philippe Cottagnoud; Lijiang Jiang; Phong Nguyen; Derek Wachtel; Guoqiang Wang; Ly T. Phan // Journal of Antimicrobial Chemotherapy (JAC);Mar2008, Vol. 61 Issue 3, p665 

    : Objectives To test the efficacy of EDP-420, a new ketolide, in experimental pneumococcal meningitis and to determine its penetration into the CSF. : Methods The experimental rabbit model was used in this study and EDP-420 was tested against a penicillin-resistant and a penicillin- and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics